Annual Current Liabilities
$24.77 M
-$3.95 M-13.75%
December 31, 2023
Summary
- As of February 8, 2025, TBPH annual total current liabilities is $24.77 million, with the most recent change of -$3.95 million (-13.75%) on December 31, 2023.
- During the last 3 years, TBPH annual current liabilities has fallen by -$98.80 million (-79.96%).
- TBPH annual current liabilities is now -79.96% below its all-time high of $123.57 million, reached on December 31, 2020.
Performance
TBPH Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$23.43 M
+$489.00 K+2.13%
September 30, 2024
Summary
- As of February 8, 2025, TBPH quarterly total current liabilities is $23.43 million, with the most recent change of +$489.00 thousand (+2.13%) on September 30, 2024.
- Over the past year, TBPH quarterly current liabilities has dropped by -$1.93 million (-7.62%).
- TBPH quarterly current liabilities is now -83.51% below its all-time high of $142.13 million, reached on September 30, 2022.
Performance
TBPH Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TBPH Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.8% | -7.6% |
| 3 y3 years | -80.0% | -64.5% |
| 5 y5 years | -74.9% | -81.0% |
TBPH Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.7% | at low | -83.5% | +8.2% |
| 5 y | 5-year | -80.0% | at low | -83.5% | +8.2% |
| alltime | all time | -80.0% | at low | -83.5% | +8.2% |
Theravance Biopharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $23.43 M(+2.1%) |
| Jun 2024 | - | $22.95 M(+5.9%) |
| Mar 2024 | - | $21.66 M(-12.5%) |
| Dec 2023 | $24.77 M(-13.7%) | $24.77 M(-2.4%) |
| Sep 2023 | - | $25.37 M(+3.3%) |
| Jun 2023 | - | $24.55 M(-6.3%) |
| Mar 2023 | - | $26.18 M(-8.8%) |
| Dec 2022 | $28.71 M(-51.0%) | $28.71 M(-79.8%) |
| Sep 2022 | - | $142.13 M(+335.7%) |
| Jun 2022 | - | $32.62 M(-26.2%) |
| Mar 2022 | - | $44.20 M(-24.6%) |
| Dec 2021 | $58.59 M(-52.6%) | $58.59 M(-11.3%) |
| Sep 2021 | - | $66.08 M(-1.6%) |
| Jun 2021 | - | $67.13 M(-22.4%) |
| Mar 2021 | - | $86.49 M(-30.0%) |
| Dec 2020 | $123.57 M(+10.6%) | $123.57 M(+18.5%) |
| Sep 2020 | - | $104.27 M(-2.2%) |
| Jun 2020 | - | $106.57 M(+8.7%) |
| Mar 2020 | - | $98.04 M(-12.2%) |
| Dec 2019 | $111.70 M | $111.70 M(+2.6%) |
| Sep 2019 | - | $108.82 M(-1.2%) |
| Jun 2019 | - | $110.14 M(-3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $113.54 M(+15.2%) |
| Dec 2018 | $98.55 M(+57.6%) | $98.55 M(-3.4%) |
| Sep 2018 | - | $102.03 M(+9.1%) |
| Jun 2018 | - | $93.48 M(-11.1%) |
| Mar 2018 | - | $105.18 M(+68.1%) |
| Dec 2017 | $62.55 M(+27.0%) | $62.55 M(+28.2%) |
| Sep 2017 | - | $48.79 M(-14.6%) |
| Jun 2017 | - | $57.10 M(+16.6%) |
| Mar 2017 | - | $48.98 M(-0.6%) |
| Dec 2016 | $49.27 M(-0.4%) | $49.27 M(+8.5%) |
| Sep 2016 | - | $45.41 M(+1.7%) |
| Jun 2016 | - | $44.66 M(-3.8%) |
| Mar 2016 | - | $46.40 M(-6.2%) |
| Dec 2015 | $49.47 M(+19.9%) | $49.47 M(+80.3%) |
| Sep 2015 | - | $27.43 M(+12.1%) |
| Jun 2015 | - | $24.48 M(-15.2%) |
| Mar 2015 | - | $28.85 M(-30.1%) |
| Dec 2014 | $41.26 M(+11.9%) | $41.26 M(+15.2%) |
| Sep 2014 | - | $35.83 M(-10.7%) |
| Jun 2014 | - | $40.11 M(+4.1%) |
| Mar 2014 | - | $38.54 M(+4.6%) |
| Dec 2013 | $36.85 M | $36.85 M |
FAQ
- What is Theravance Biopharma annual total current liabilities?
- What is the all time high annual current liabilities for Theravance Biopharma?
- What is Theravance Biopharma annual current liabilities year-on-year change?
- What is Theravance Biopharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Theravance Biopharma?
- What is Theravance Biopharma quarterly current liabilities year-on-year change?
What is Theravance Biopharma annual total current liabilities?
The current annual current liabilities of TBPH is $24.77 M
What is the all time high annual current liabilities for Theravance Biopharma?
Theravance Biopharma all-time high annual total current liabilities is $123.57 M
What is Theravance Biopharma annual current liabilities year-on-year change?
Over the past year, TBPH annual total current liabilities has changed by -$3.95 M (-13.75%)
What is Theravance Biopharma quarterly total current liabilities?
The current quarterly current liabilities of TBPH is $23.43 M
What is the all time high quarterly current liabilities for Theravance Biopharma?
Theravance Biopharma all-time high quarterly total current liabilities is $142.13 M
What is Theravance Biopharma quarterly current liabilities year-on-year change?
Over the past year, TBPH quarterly total current liabilities has changed by -$1.93 M (-7.62%)